Geron Corp (GERN) Opciones

Its the "Too Little Tooo Late" story for GERN..
LOLC??? SMH
KARMA

Shouldn’t be down here but it is. Analyst are all over the place. Institutional holdings look good so far unless they’re dumping. We need a more dynamic management, IMO.

“B. Riley downgrades to Neutral from Buy, Cuts target to $2 from $3.50”

looking for 2.25 by next week

Sold the15K at 1.75

That’s all I need too. You know their governance over on the other board is atrocious, right? Rarely leads to anything good. At least Geron’s management bench runs deep. I wish they’d be more active with open market purchases but if the company is really in takeover mode that wouldn’t be possible, of course. Three presentations coming in the next weeks. We’ll see.

Here we agree. On the other board not so much.

By the way, I only have one account on ihub.

It would be one explanation for the action today and faux stock downgrades.

“Wedbush Lowers Geron’s Price Target to $7 from $8, Outperform Raiting Maintained”

The takedown before the buyout!!

The same happen with HGSI

LOLC2020 - You pumped it, Its failing & you now saying "THE COMPANY IS SOLID", BUT the "ANALYSTS SEEM INTENT ON SETTING THE STOCK FOR FAILURE??

Who pays you for such misjudged PUMP Efforts here & FUD Efforts there???

This would be a very good time for some open market purchases by management.

The company seems solid but the analyst seem intent on setting up the stock for failure.

And you think someone would believe that why?

Great purchase. picked up another 5k @ 1.92

All seems good but the stock is always a death trap.

>>Selling, general and administrative expenses for the three and twelve months ended December 31, 2024, were $43.4 million, and $145.7 million, respectively, and $21.4 million and $69.1 million for the same periods in 2023. The increase in general and administrative expenses in 2024 as compared to 2023 primarily reflects higher personnel-related expenses related to increased headcount to support commercial launch of RYTELO in the U.S. and stock-based compensation expense recognized upon FDA approval of RYTELO due to the vesting of performance-based stock options.

picked up another 10000 at 1.60

Stock on the verge of merger/acquisition.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175821245

Grrron stock is just a disgrace…A perpetual retail trap.

picked up another 4500@ $2.40

pushing this thing down low with no news and no volume, amazing. Will wait till Wednesday before making decision.

But in your Case, LC2020, a response from GROK not needed as ihub has all of YOU!!!

You have been made - Historical/Present Records Been Collected!!

KARMA!!

Earnings next week….looking for revs in the $40-$50 mil range…..up nicely from last quarter…hopefully some sort of update on European drug approval….that should happen mid year….only way to go is up from here

What are you babbling about now?

LC-2020,

You know Your Effort to Earn are Well Documented, RIGHT??

KARMA

A coming next week.

WTF! Is Geron stock just a forever retail trap or are we going to see a real run?

“B. Riley Adjusts target to $3.50 From $5.50, Maintains Buy Rating”

LOL -LC2020: And as per your folowing post..

>>> That should give them about another month to dump shares before we learn anything>>>

There has never been "WE". You paid to work against the "WE", you pretend to be part of...
KARMA!!!!

Grrrrron. So disappointing. Hopefully just a shake out before the coming q report.

What do you mean, I’ve been somewhat supportive of Geron?

You and the other disciples always get it wrong.

https://x.com/CitizenFreePres/status/1889688886789464305

Hopefully market acceptance increasing. Buyout is always on the table now that they said they likely won’t do a cash raise. I’m hoping for some long-shot unexpected benefit suddenly seen in some other indication.

Better than expected revenues? Date when they expect European approval?…..I’m buying call options !!!!!!…..not shares

Someone knows something? High volume the last week, with a sizeable uptick.

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it will release its fourth quarter and full-year 2024 financial results and business highlights before the market opens on Wednesday, February 26, 2025 via press release, which will be available on the Company’s website at www.geron.com/investors. Geron will host a conference call to discuss the financial results as well as business highlights at 8:00 a.m. Eastern Time the same day.

You are a Karmic Poison to You!!

https://s201.q4cdn.com/710325604/files/doc_presentations/2025/Jan/13/JPM-2025-Corporate-Slides_final-2.pdf

Who knows?? IBB is going sideways, New POTUS, nervous market. Perhaps a buyout is coming?? Perhaps something we’re not being told?? You never know in the biotech space. But all I can say is Geron has never looked better in the decades I’ve been around.

why the stock is doing so poorly

The MMs are on the hook for too many options in the money above $3....Wait for move next week.

Ok fair enough but tell me why the stock is doing so poorly

Umm…what I put in quotes maybe? ~$45M in net revs for 2024 with hopefully full Rytelo market acceptance in 2025 and other indications to come. Quickly growing up. I like it.

I’m curious as to what looks good about this to you . Please enlighten me

LOL. Looks good to me. “Positioned for Profitability Without Additional Financing”.

Ugly. 8k out. What am I missing?

It’s getting exactly what I said it would get . I hope some people listened to me and sold and did not listen to the morons on this board . You know who they are

GERN. 10 day hourly

Heavy accumulation 😆

LC2020. Posting Paid trash 24/7 is his very proud way of living...

SMH,,,, KARMIC Trap....

I agree, that is why I keep adding. product approved with great results. Just waiting for the true breakout 😃

Grrrrrrrron, as usual.  Here's hoping for some real sp traction in '25! 

Yup, foresure...I forgot that one!